UNSPSC 51201830: Pegademase

This classification denotes an industrial aid, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier HW3H7D91F6. European Medicines Agency schedules Pegademase bovine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30488. Pegademase generally arises in the molecular formula C5H8NO3(C2H4O)N. The term PEGADEMASE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 5, no. 3 1991, list 31.)

UNSPSC 51201830 Pegademase is a Commodity code that covers specialized pharmaceutical products, but recent state and local solicitation activity under this code shows minimal relevant procurement. The single recent opportunity posted under this code — a July 2026 notice from the Mississippi State Department of Health — is actually a sole-source procurement for Yellow Fever Vaccine from Sanofi Pasteur, Inc., which falls outside the scope of pegademase (an enzyme replacement therapy used in adenosine deaminase deficiency treatment). The mismatch between the code's nominal scope and the vaccine being procured suggests either a tagging error or that the code sees little substantive state and local activity aligned with its intended pharmaceutical category.

No additional recent opportunities supporting pegademase procurement are present in the current activity stream. State and local procurement under this code tier does not show active competitive demand or multiple issuing bodies pursuing the product. Business development professionals should verify whether state and local health departments, hospitals, or specialty pharmaceutical procurement vehicles actually source pegademase through state and local channels, or whether this commodity moves primarily through federal and private healthcare supply chains rather than traditional state and local government procurement.